The phase 3 SKYSCRAPER-01 trial of tiragolumab and atezolizumab in PD-L1-high non–small cell lung cancer did not meet its primary end point of overall survival.
A retrospective study revealed differences in metastasis patterns and treatment utilization by ethnicity among patients with breast cancer and brain metastasis.
Researchers at the University of Cologne and the Centre (CRG) in Barcelona have discovered that cancer grows uniformly throughout its mass, rather than at the outer edges.